- Our Services
-
Patients and Families
- Get Directions
- Parking
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
Planning a Visit
- Find a Doctor
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
Parents
- For Health Professionals
- Research
- Ways to Give
-
News
-
Adding Breast Milk Ingredient to Formula Could Prevent Deadly Intestinal Problem in Premature Babies
-
Children's Holds Groundbreaking Ceremony for Expansion to New South Fayette Location
-
Child Neurodevelopmental and Mental Health Disabilities on the Rise, Study Finds
News Releases
-
Research
Infant Cholestasis Database
A Prospective Database of Infants With Cholestasis
Protocol Description
The purpose of this research is to establish a prospective national database with demographic and clinical information about infants with cholestatic disease and their families. The database will provide a means of prospectively following these children over time to characterize the natural history of the disease, and to identify environmental, infectious and genetic risk factors related to onset, to outcome and treatment success for the different cholestatic diseases, with special emphasis on biliary atresia. Another aim of the study is to establish repositories for blood, urine, bile and tissue samples from these children and blood samples from their biological parents for future research studies on liver diseases.
This study is being conducted through the Childhood Liver Disease Research and Education Network (ChiLDREN), a network of 15 clinical sites in the United States and Canada.
Eligibility Criteria
Infants no older than 6 months, with a diagnosis of clinically meaningful cholestasis due to primary hepatobiliary disease.
Boys: Newborn through 180 days
Girls: Newborn through 180 days
Requirements
Participants will make a series of visits for physical examinations that will include collection of blood and urine samples, as would normally be done through routine clinic visits for patients with cholestasis. Visits generally are scheduled at 1, 2, 3 and 6 months following diagnosis and at 12, 18 and 24 months of age, and then annually until age 10. The parents or guardians of participants will be asked to maintain a journal of the patient’s medical visits and any new medications or changes in medications prescribed for the patient.
Visits: 15
Duration: 10 years
Status: Open for Enrollment
Source of Support
National Institutes of Health
Additonal Resources
Study summary at National Institutes of Health
Biliary Atresia
Primary Investigator(s)
Benjamin L. Shneider, MD
Contact Information
To get started, please contact:
Beverly Bernard, CRNP
412-692-5811
Last Update
May 5, 2010
May 5, 2010
